Science Explorer Back to mapMap
Discussion
Researcher · Jubilant Life Sciences (India) · India

Sreekala Nair

Sreekala Nair publishes mostly in Molecular Biology, Epidemiology and Infectious Diseases, on topics such as Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation and Protein Degradation and Inhibitors.

OpenAlex
World rank
#5,031,989
of 7,710,434 ranked researchers
Rank in India
#138,460
of 280,097
Works
21
Citations
240
Citations per work
11.4
h-index
7
i10-index 5Top 91% in Molecular Biology
Sreekala Nair

What does Sreekala Nair research?

Sreekala Nair's work is mostly in Biochemistry, Genetics and Molecular Biology (53%), Medicine (21%), Chemistry (3%).

Life Sciences: 11 works · 53.4% of their workBiochemistry, Genetics and Molecular Biology: 11 works · 53.4% of their workMolecular Biology: 11 works · 53.4% of their workEverything else: 5 works · 22.6% of their workHealth Sciences: 4 works · 20.6% of their workMedicine: 4 works · 20.6% of their workEpidemiology: 2 works · 8.6% of their workInfectious Diseases: 1 works · 5.2% of their workOncology: 1 works · 3.4% of their workPublic Health, Environmental and Occupational Health: 1 works · 3.4% of their workPhysical Sciences: 1 works · 3.4% of their workChemistry: 1 works · 3.4% of their workOrganic Chemistry: 1 works · 3.4% of their workTHEIR WORKSreekala Nair21works
Life Sciences53%Physical Sciences3%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1153.4%
  2. Everything else522.6%
    1. Medicine420.6%
    1. Chemistry13.4%
  1. 1Molecular Biology53% of their works
  2. 2Epidemiology9% of their works
  3. 3Infectious Diseases5% of their works
  4. 4Oncology3% of their works
  5. 5Organic Chemistry3% of their works
  6. 6Public Health, Environmental and Occupational Health3% of their works

Research topics

Which keywords describe Sreekala Nair's research?

The keywords of their largest research topics: Cancer Therapy, Epigenetic Regulation, HDAC Inhibitors, Histone Deacetylases, Transcriptional Regulation, DNA Methylation, Histone Modification and BET Bromodomains.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer Therapy112 topics
  2. Epigenetic Regulation112 topics
  3. HDAC Inhibitors91 topic
  4. Histone Deacetylases91 topic
  5. Transcriptional Regulation82 topics
  6. DNA Methylation71 topic
  7. Histone Modification71 topic
  8. BET Bromodomains61 topic
  9. PROTACs61 topic
  10. Cancer42 topics
  11. Herpes Zoster31 topic
  12. Herpesviruses31 topic
  13. ADAR Deaminases21 topic
  14. Apoptosis21 topic
  15. Arginine Methylation21 topic
  16. Cell Death21 topic
  17. HIF-121 topic
  18. Protein Arginine Methyltransferases21 topic
  19. RNA Editing21 topic
  20. Warburg Effect21 topic

Where does Sreekala Nair work?

Sreekala Nair's main affiliation in the publication record is Jubilant Life Sciences (India), India.

How many publications and citations does Sreekala Nair have?

OpenAlex counts 21 works and 240 citations for Sreekala Nair, an h-index of 7, ranking #5,031,989 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sreekala Nair. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.